Back to Journals » OncoTargets and Therapy » Volume 12

Chinese perspectives on clinical efficacy and safety of alectinib in patients with ALK-positive advanced non-small cell lung cancer

Total article views   HTML views PDF downloads Totals
7,453 Dovepress* 6,193+ 1,340 7,533
PubMed Central* 1,260 305 1,565
Totals 7,453 1,645 9,098
*Since 14 August 2019
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar